Search

The EU has planned the phase-out of new vehicles based on internal combustion engines in favor of high-efficiency battery electric vehicles (BEV) by 2035 (Fit for 55 package). However, many doubts remain about the effectiveness of this choice for each country of the Union in terms of CO2 emissions reduction, as each State is characterized by a different carbon intensity related to the production of electricity needed to manufacture and recharge vehicles. This study seeks to explore the Italian case. To this aim, carbon intensities related to electricity production were calculated considering both the Italian electricity mix production in 2022 and those envisaged in 2035, considering two energy scenarios based on different introductions of renewable energy sources (RES). Afterward, the values obtained were adopted for determining the CO2 emissions related to the whole production process of battery systems in Italy (emissions from mining and refining, scrap materials, and final assembly included) by comparing some of the most up-to-date Life-Cycle Assessment (LCA) analyses related to the manufacturing cycle of the batteries. Finally, the results were adopted to calculate the starting carbon debit for A, B, C, and M car segments for Mild Hybrid, Full Hybrid, and Full Electric powertrains. At the same time, statistical road fuel/electricity consumption data were collected and overall CO2 emissions were calculated for the same vehicles adopting a dynamic approach and plotted for a defined distance, so as to determine break-even points with respect to the cumulative (i.e., from battery and road) carbon emissions. The results showed that advantages related to electric vehicles are significant only if a low carbon intensity related to electricity production is reached by means of a very high introduction of RES, thus keeping the door open for innovative hybrid powertrain technologies, if fed with low carbon fuels. [ABSTRACT FROM AUTHOR]

Isolated REM sleep behaviour disorder (RBD) is an early-stage α-synucleinopathy in most, if not all, affected subjects. Detection of pathological α-synuclein in peripheral tissues of patients with isolated RBD may identify those progressing to Parkinson's disease, dementia with Lewy bodies or multiple system atrophy, with the ultimate goal of testing preventive therapies. Real-time quaking-induced conversion (RT-QuIC) provided evidence of α-synuclein seeding activity in CSF and olfactory mucosa of patients with α-synucleinopathies. The aim of this study was to explore RT-QuIC detection of α-synuclein aggregates in olfactory mucosa of a large cohort of subjects with isolated RBD compared to patients with Parkinson's disease and control subjects. This cross-sectional case-control study was performed at the Medical University of Innsbruck, Austria, the Hospital Clinic de Barcelona, Spain, and the University of Verona, Italy. Olfactory mucosa samples obtained by nasal swab in 63 patients with isolated RBD, 41 matched Parkinson's disease patients and 59 matched control subjects were analysed by α-synuclein RT-QuIC in a blinded fashion at the University of Verona, Italy. Median age of patients with isolated RBD was 70 years, 85.7% were male. All participants were tested for smell, autonomic, cognitive and motor functions. Olfactory mucosa was α-synuclein RT-QuIC positive in 44.4% isolated RBD patients, 46.3% Parkinson's disease patients and 10.2% control subjects. While the sensitivity for isolated RBD plus Parkinson's disease versus controls was 45.2%, specificity was high (89.8%). Among isolated RBD patients with positive α-synuclein RT-QuIC, 78.6% had olfactory dysfunction compared to 21.4% with negative α-synuclein RT-QuIC (P < 0.001). The extent of olfactory dysfunction was more severe in isolated RBD patients positive than negative for olfactory mucosa a-synuclein RT-QuIC (P < 0.001). We provide evidence that the α-synuclein RT-QuIC assay enables the molecular detection of neuronal α-synuclein aggregates in olfactory mucosa of patients with isolated RBD and Parkinson's disease. Although the overall sensitivity was moderate in this study, nasal swabbing is attractive as a simple, non-invasive test and might be useful as part of a screening battery to identify subjects in the prodromal stages of α-synucleinopathies. Further studies are needed to enhance sensitivity, and better understand the temporal dynamics of α-synuclein seeding in the olfactory mucosa and spreading to other brain areas during the progression from isolated RBD to overt α-synucleinopathy, as well the impact of timing, disease subgroups and sampling technique on the overall sensitivity. [ABSTRACT FROM AUTHOR]